Journal of Obesity

Pharmacologic Treatment of Obesity


Publishing date
15 Nov 2010
Status
Published
Submission deadline
15 May 2010

Lead Editor

1University of São Paulo, São Paulo, Brazil

2Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Antwerp, Belgium


Pharmacologic Treatment of Obesity

Description

Obesity is a serious disease with many associated comorbidities and should be effectively treated. In many obese patients, treatment based on only lifestyle interventions may not result in desirable weight loss and the availability of effective complementary drug treatment would be desirable.

The special issue on pharmacologic treatment of obesity is now requesting submission of original research and review articles with main topics of interest including, but not limited to, animal and human studies of:

  • New central and peripheral targets
  • Mechanism of drug action
  • Pharmacogenomics
  • New biomarkers
  • New/novel experimental study designs
  • Randomized controlled clinical trials, including in selected populations
  • Comorbidity effects
  • Combination drug treatments
  • Future perspectives

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jobes/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2011
  • - Article ID 252817
  • - Review Article

AMPK as Target for Intervention in Childhood and Adolescent Obesity

Joselyn Rojas | Nailet Arraiz | ... | Valmore Bermúdez
  • Special Issue
  • - Volume 2011
  • - Article ID 928165
  • - Review Article

Pharmacological Treatment of Obesity in Children and Adolescents: Present and Future

Lorenzo Iughetti | Mariachiara China | ... | Barbara Predieri
  • Special Issue
  • - Volume 2011
  • - Article ID 402052
  • - Review Article

Pharmacological Treatment of Obesity in Patients with Polycystic Ovary Syndrome

Hassan Kahal | Stephen L. Atkin | Thozhukat Sathyapalan
  • Special Issue
  • - Volume 2011
  • - Article ID 509038
  • - Review Article

The Use of Garcinia Extract (Hydroxycitric Acid) as a Weight loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials

Igho Onakpoya | Shao Kang Hung | ... | Edzard Ernst
  • Special Issue
  • - Volume 2011
  • - Article ID 179674
  • - Review Article

Pharmacotherapies for Obesity: Past, Current, and Future Therapies

Lisa L. Ioannides-Demos | Loretta Piccenna | John J. McNeil
  • Special Issue
  • - Volume 2011
  • - Article ID 686521
  • - Research Article

Canadian Physicians' Use of Antiobesity Drugs and Their Referral Patterns to Weight Management Programs or Providers: The SOCCER Study

R. S. Padwal | S. Damjanovic | ... | A. M. Sharma
  • Special Issue
  • - Volume 2011
  • - Article ID 806896
  • - Research Article

Taking Orlistat: Predicting Weight Loss over 6 Months

Amelia Hollywood | Jane Ogden
  • Special Issue
  • - Volume 2011
  • - Article ID 431985
  • - Review Article

Anti-Inflammatory Nutrition as a Pharmacological Approach to Treat Obesity

Barry Sears | Camillo Ricordi
  • Special Issue
  • - Volume 2011
  • - Article ID 984245
  • - Review Article

Weight Considerations in Pharmacotherapy for Type 2 Diabetes

Vicky Cheng | Sangeeta R. Kashyap
  • Special Issue
  • - Volume 2011
  • - Article ID 548140
  • - Research Article

Roles of Adiponectin and Oxidative Stress in the Regulation of Membrane Microviscosity of Red Blood Cells in Hypertensive Men—An Electron Spin Resonance Study

Kazushi Tsuda
Journal of Obesity
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision85 days
Acceptance to publication14 days
CiteScore7.400
Journal Citation Indicator0.700
Impact Factor3.3
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.